Increased amounts of specific TAM subsets identified by CD163, CD206, stabilin-1, and TREM2 biomarkers correlate with both hematogenous and lymphatic metastasis in all cancer types studied [21, 34, 47, 50, 54–58]. Here, CD163 is linked to cancer.